Advocate Health partners with AI startup to connect more cancer patients to Clinical Trials.
Article excerpt
Advocate Health partners with AI startup to connect more cancer patients to Clinical Trials. Clinician-guided AI partnership aims to improve clinical trial screening and enrollment. Newswise - CHARLOTTE, N.C. - Advocate Health is reinforcing its role as a national leader in oncology care and artificial intelligence innovations by partnering with Lind to help connect more cancer patients to potentially life-saving clinical trials. Lind is an AI platform designed for health systems to improve how patients are identified and matched to cancer clinical trials. The partnership reflects Advocate Health's long-term commitment to responsibly advancing AI as a critical part of the future of healthcare. Currently, clinical trial matching for cancer patients is one of the biggest barriers to accelerating cancer research. The manual screening processes are laborious, inconsistent across sites of care and difficult to scale. This results in only 5% of eligible patients across the nation participating in clinical trials. Lind simplifies the process. The platform will be embedded into an electronic health record and automatically screens patients for clinical trials. Lind works alongside clinicians, not instead of, and allows clinician oversight before enrolling a patient into a trial. The human-plus-AI model supports better workflows, patient experiences and efficiencies. "There...
Keep reading with a free account
The rest of this article, and every signal for Advocate Health, is in your free account.
Extracted from this sentence
"By partnering with Lind, Advocate Health will ensure more patients have access to potentially life-changing treatments without replacing the critical role our clinicians have.
